XML 52 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
Restructuring and Related Charges (Tables)
12 Months Ended
Dec. 31, 2023
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Liabilities

The following table summarizes the change in the Company’s restructuring and other related liabilities for the years ended December 31, 2023 and 2022 (in thousands):

 

 

 

Severance
and other
employee-
related
benefits
(1)

 

 

Facility
Costs

 

 

Other(2)

 

 

Total

 

Balance at December 31, 2021

 

$

 

 

$

 

 

$

 

 

$

 

Restructuring and related charges

 

 

5,849

 

 

 

2,885

 

 

 

998

 

 

 

9,732

 

Cash payments

 

 

(1,835

)

 

 

(2,885

)

 

 

(979

)

 

 

(5,699

)

Balance at December 31, 2022

 

$

4,014

 

 

$

 

 

$

19

 

 

$

4,033

 

Restructuring and related charges

 

 

2,379

 

 

 

4,160

 

 

 

537

 

 

 

7,076

 

Cash payments

 

 

(5,568

)

 

 

(4,160

)

 

 

(556

)

 

 

(10,284

)

Balance at December 31, 2023

 

$

825

 

 

$

 

 

$

 

 

$

825

 

 

(1)
Restructuring liabilities are recorded in accrued compensation and related benefits on the consolidated balance sheets.
(2)
Other restructuring liabilities are comprised mainly of sublease commissions and are recorded in other accrued liabilities on the consolidated balance sheets.

The Company’s restructuring and related charges by segment and corporate were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Restructuring:

 

 

 

 

 

 

Proteomics

 

$

1,010

 

 

$

1,363

 

Genomics

 

 

714

 

 

 

1,273

 

Corporate expenses

 

 

5,352

 

 

 

7,096

 

Total restructuring and related charges

 

$

7,076

 

 

$

9,732